Official source Data mirrored from Centers for Medicare & Medicaid Services Open Payments · General Payments · as published 2026-01-23 View official record Methodology

Covered recipient · General Payments record

RAJENDRAN ALAPPAN

Allopathic & Osteopathic Physicians Internal Medicine Nephrology

NPI
1225024557
CMS profile
55435
Location
COLUMBUS, GA

General Payments · PY2018–2024

$74,049.08

  • Reported across 228 records
  • CMS publication 2026-01-23

Latest program year · PY2024

$3,955.78

32 records · 0 disputed

Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.

How these totals are calculated
  • The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
  • Methodology & Data — sourcing, labeling, and limitations.

By nature of payment

PY2024 · sorted by reported total

By paying entity

PY2024 · sorted by reported total

By program year

All program years on this page · sorted by year

Program yearAmountRecords
PY2018 $436.52 11
PY2019 $23,682.89 50
PY2020 $7,425.09 18
PY2021 $5,589.44 17
PY2022 $14,107.97 39
PY2023 $18,851.39 61
PY2024 $3,955.78 32

Payment records · PY2024 (32)

Sorted by paying entity, then date · as published by CMS

Program year 2024 201820192020202120222023 Record-level detail is published for PY2024; earlier years are summarised in “By program year”.
Paying entity Amount Date Nature of payment Dispute status Published Record ID Source
AKEBIA THERAPEUTICS INC $24.61 09/25/2024 Education Undisputed 01/23/2026 1145833419 CMS
Alnylam Pharmaceuticals Inc. $16.50 03/28/2024 Food and Beverage Undisputed 01/23/2026 1125826957 CMS
Amgen Inc. $34.65 05/15/2024 Food and Beverage Undisputed 01/23/2026 1115414775 CMS
AstraZeneca Pharmaceuticals LP $100.00 01/23/2024 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program Undisputed 01/23/2026 1104283227 CMS
AstraZeneca Pharmaceuticals LP $100.00 01/23/2024 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program Undisputed 01/23/2026 1105211547 CMS
AstraZeneca Pharmaceuticals LP $17.41 03/09/2024 Food and Beverage Undisputed 01/23/2026 1104346702 CMS
AstraZeneca Pharmaceuticals LP $21.18 04/04/2024 Food and Beverage Undisputed 01/23/2026 1104635701 CMS
AstraZeneca Pharmaceuticals LP $21.89 04/18/2024 Food and Beverage Undisputed 01/23/2026 1104272549 CMS
AstraZeneca Pharmaceuticals LP $1,450.00 04/26/2024 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program Undisputed 01/23/2026 1105600103 CMS
AstraZeneca Pharmaceuticals LP $27.61 05/18/2024 Food and Beverage Undisputed 01/23/2026 1105393168 CMS
AstraZeneca Pharmaceuticals LP $15.04 08/12/2024 Food and Beverage Undisputed 01/23/2026 1104729721 CMS
AstraZeneca Pharmaceuticals LP $19.09 10/30/2024 Food and Beverage Undisputed 01/23/2026 1104248573 CMS
AstraZeneca Pharmaceuticals LP $15.93 12/17/2024 Food and Beverage Undisputed 01/23/2026 1105672719 CMS
Baxter Healthcare $24.64 05/06/2024 Food and Beverage Undisputed 01/23/2026 1120626502 CMS
Baxter Healthcare $33.35 10/29/2024 Food and Beverage Undisputed 01/23/2026 1120626482 CMS
Bayer Healthcare Pharmaceuticals Inc. $21.10 04/06/2024 Food and Beverage Undisputed 01/23/2026 1086176314 CMS
CALLIDITAS THERAPEUTICS US INC. $17.73 10/29/2024 Food and Beverage Undisputed 01/23/2026 1141525772 CMS
GlaxoSmithKline, LLC. $1,625.00 05/01/2024 Consulting Fee Undisputed 01/23/2026 1116422737 CMS
GlaxoSmithKline, LLC. $141.48 05/13/2024 Travel and Lodging Undisputed 01/23/2026 1116260192 CMS
Kyowa Kirin, Inc. $22.37 12/12/2024 Food and Beverage Undisputed 01/23/2026 1127040815 CMS
Mallinckrodt Hospital Products Inc. $37.88 11/01/2024 Food and Beverage Undisputed 01/23/2026 1145045611 CMS
Novartis Pharmaceuticals Corporation $30.64 09/09/2024 Food and Beverage Undisputed 01/23/2026 1086750419 CMS
Novo Nordisk Inc $16.44 06/04/2024 Food and Beverage Undisputed 01/23/2026 1096714549 CMS
Novo Nordisk Inc $14.61 09/12/2024 Food and Beverage Undisputed 01/23/2026 1096661512 CMS
OPKO Pharmaceuticals, LLC $16.24 01/12/2024 Food and Beverage Undisputed 01/23/2026 1112841788 CMS
Otsuka America Pharmaceutical, Inc. $28.26 05/14/2024 Food and Beverage Undisputed 01/23/2026 1118850466 CMS
Travere Therapeutics, Inc. $3.08 01/26/2024 Education Undisputed 01/23/2026 1149940296 CMS
Travere Therapeutics, Inc. $16.89 01/26/2024 Education Undisputed 01/23/2026 1149940304 CMS
Travere Therapeutics, Inc. $21.82 02/16/2024 Food and Beverage Undisputed 01/23/2026 1149940312 CMS
Travere Therapeutics, Inc. $0.37 06/11/2024 Education Undisputed 01/23/2026 1149940292 CMS
Travere Therapeutics, Inc. $3.08 06/11/2024 Education Undisputed 01/23/2026 1149940300 CMS
Travere Therapeutics, Inc. $16.89 06/11/2024 Education Undisputed 01/23/2026 1149940308 CMS

Source & provenance

Dataset
CMS Open Payments — General Payments
Publisher of source data
Centers for Medicare & Medicaid Services
CMS publication date
2026-01-23
Program years on this page
2018, 2019, 2020, 2021, 2022, 2023, 2024
Source files
Dataset page · Bulk file · PY2018 , PY2019 , PY2020 , PY2021 , PY2022 , PY2023 , PY2024
Generated from
OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.